SCHEMBL18618658

SCHEMBL18618658

CCN(CC)c1ccc2cc(C(=O)NC[C@H](N)C(C)=O)c(=O)oc2c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 9/20 0.65
▸ MEN1 O00255 8/20 0.65
▸ MAPT P10636 7/20 0.65
▸ MAOB P27338 4/20 0.65
▸ ATM Q13315 4/20 0.65
▸ USP2 O75604 2/20 0.65
▸ CYP1A2 P05177 1/20 0.65
▸ CYP2C19 P33261 1/20 0.65
▸ ALDH1A1 P00352 5/20 0.64
▸ HPGD P15428 4/20 0.64
▸ SMN1; SMN2 Q16637 3/20 0.64
▸ KDM4E B2RXH2 4/20 0.61
▸ HSD17B10 Q99714 2/20 0.61
▸ SLC16A3 O15427 1/20 0.61
▸ ALOX15 P16050 1/20 0.61
▸ SLC16A1 P53985 1/20 0.61
▸ GBA1 P04062 1/20 0.59
▸ NPC1 O15118 1/20 0.56
▸ STAT3 P40763 1/20 0.56
▸ STAT1 P42224 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27310284 0.92 ALDH1A1 (0.65) KMT2AMEN1MAPTMAOBATM
SCHEMBL27309210 0.88 KMT2A (0.59) KMT2AMEN1MAPTMAOBATM
SCHEMBL15179178 0.87 KMT2A (0.64) KMT2AMEN1MAPTMAOBATM
SCHEMBL19686997 0.87 KMT2A (0.64) KMT2AMEN1MAPTMAOBATM
SCHEMBL16293207 0.84 KMT2A (0.73) KMT2AMEN1MAPTMAOBATM
SCHEMBL17644096 0.84 AKR1B10 (0.61) KMT2AMEN1MAPTMAOBALDH1A1
SCHEMBL13081989 0.84 KMT2A (0.70) KMT2AMEN1MAPTMAOBATM
SCHEMBL13403918 0.83 KMT2A (0.71) KMT2AMEN1MAPTMAOBATM
SCHEMBL580009 0.83 MEN1 (0.77) KMT2AMEN1MAPTMAOBATM
SCHEMBL29611843 0.83 MEN1 (0.77) KMT2AMEN1MAPTMAOBATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017040990-A1 PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF AILERON THERAPEUTICS, INC. (US) 2017-03-09 — — WO disclosed
Send feedback